We subsequently investigated the distinctive features of the tumor immune microenvironment of tumors with FGFR2 fusions or rearrangements (FGFR2+ cohort) as compared to tumors without FGFR2 fusions or rearrangements (FGFR2 WT cohort). Here, FGFR2 is linked to neoplasm.